Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission
Condition(s):Giant Cell ArteritisLast Updated:February 2, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Giant Cell ArteritisLast Updated:February 2, 2024Recruiting
Condition(s):TAKAYASU ARTERITISLast Updated:August 19, 2020Completed
Condition(s):Giant Cell ArteritisLast Updated:December 21, 2022Recruiting
Condition(s):Giant Cell ArteritisLast Updated:September 22, 2023Not yet recruiting
Condition(s):Takayasu ArteritisLast Updated:September 25, 2020Unknown status
Condition(s):Temporal ArteritisLast Updated:May 26, 2010Unknown status
Condition(s):Giant Cell ArteritisLast Updated:August 10, 2017Unknown status
Condition(s):Takayasu’s ArteritisLast Updated:April 12, 2022Recruiting
Condition(s):Giant Cell ArteritisLast Updated:August 24, 2023Not yet recruiting
Condition(s):Takayasu ArteritisLast Updated:June 20, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.